Generic substitution
Br J Clin Pharmacol
.
2011 Nov;72(5):731-2.
doi: 10.1111/j.1365-2125.2011.03920.x.
Authors
John Posner
1
,
John P Griffin
Affiliation
1
John Posner Consulting, Kent Asklepieion Consultancy Ltd, Herts, UK. john.posner@talk21.com
PMID:
21988164
PMCID:
PMC3243006
DOI:
10.1111/j.1365-2125.2011.03920.x
No abstract available
MeSH terms
Cost-Benefit Analysis
Delivery of Health Care / economics
Delivery of Health Care / trends*
Drug Substitution*
Drugs, Generic*
Humans
United Kingdom
Substances
Drugs, Generic